{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:39:38Z","timestamp":1763177978749,"version":"3.45.0"},"reference-count":158,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neurol.2025.07.008","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:43:21Z","timestamp":1762962201000},"page":"893-908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Markers of presymptomatic amyotrophic lateral sclerosis: State of the art, practical implications and perspectives"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3096-6514","authenticated-orcid":false,"given":"M.-H.","family":"Soriani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Corcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8290-270X","authenticated-orcid":false,"given":"V.","family":"Danel-Brunaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Desmaison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-F.","family":"Pradat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Querin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vourch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2025.07.008_bib0795","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2025.07.008_bib0800","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1212\/WNL.0000000000207474","article-title":"Global prevalence and incidence of amyotrophic lateral sclerosis: a systematic review","volume":"101","author":"Wolfson","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib0805","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2025.07.008_bib0810","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2025.07.008_bib0815","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/jnnp-2021-326266","article-title":"Split-hand and split-limb phenomena in amyotrophic lateral sclerosis: pathophysiology, electrophysiology and clinical manifestations","volume":"92","author":"Corcia","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib0820","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0825","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.neurol.2021.03.001","article-title":"Phenotypic variability in amyotrophic lateral sclerosis","volume":"177","author":"Couratier","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2025.07.008_bib0830","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0835","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1212\/WNL.0000000000013123","article-title":"Amyotrophic lateral sclerosis-frontotemporal dementia: shared and divergent neural correlates across the clinical spectrum","volume":"98","author":"Cividini","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib0840","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/17482968.2011.551940","article-title":"Isolated bulbar phenotype of amyotrophic lateral sclerosis","volume":"12","author":"Burrell","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.neurol.2025.07.008_bib0845","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","article-title":"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0850","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurol.2025.07.008_bib0855","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/cells12111523","article-title":"Current state and future directions in the therapy of ALS","volume":"12","author":"Tzeplaeff","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neurol.2025.07.008_bib0860","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2025.07.008_bib0865","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10072-025-07994-2","article-title":"Tofersen for SOD1 amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"46","author":"Hamad","year":"2025","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurol.2025.07.008_bib0870","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/21678421.2024.2375330","article-title":"Treatment continuity of amyotrophic lateral sclerosis with available riluzole formulations: state of the art and current challenges in a \u2018real-world\u2019 setting","volume":"26","author":"Corcia","year":"2025","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.008_bib0875","first-page":"CD001447","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"2012","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2025.07.008_bib0880","first-page":"61","article-title":"Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis","volume":"7","author":"Hinchcliffe","year":"2017","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"10.1016\/j.neurol.2025.07.008_bib0885","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/21678421.2020.1771734","article-title":"Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis","volume":"21","author":"Andrews","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.008_bib0890","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fneur.2018.00442","article-title":"Clinical staging of amyotrophic lateral sclerosis in Chinese patients","volume":"9","author":"Chen","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0895","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/21678421.2016.1188961","article-title":"Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS","volume":"17","author":"Geevasinga","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.008_bib0900","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp-2024-334339","article-title":"Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS\/FTD","volume":"96","author":"Benatar","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib0905","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/WCO.0000000000001168","article-title":"Presymptomatic amyotrophic lateral sclerosis: from characterization to prevention","volume":"36","author":"Benatar","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0910","doi-asserted-by":"crossref","first-page":"105323","DOI":"10.1016\/j.ebiom.2024.105323","article-title":"Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis","volume":"108","author":"Benatar","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neurol.2025.07.008_bib0915","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s13311-022-01237-4","article-title":"Design of a randomized, placebo-controlled, phase 3 trial of tofersen initiated in clinically presymptomatic SOD1 variant carriers: the ATLAS study","volume":"19","author":"Benatar","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurol.2025.07.008_bib0920","doi-asserted-by":"crossref","first-page":"104521","DOI":"10.1016\/j.ebiom.2023.104521","article-title":"Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers","volume":"90","author":"Dorst","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neurol.2025.07.008_bib0925","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion","volume":"84","author":"Benatar","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0930","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","article-title":"Fluid biomarkers for amyotrophic lateral sclerosis: a review","volume":"19","author":"Irwin","year":"2024","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurol.2025.07.008_bib0935","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/acn3.50890","article-title":"Serum neurofilament heavy chains as early marker of motor neuron degeneration","volume":"6","author":"De Schaepdryver","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0940","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/21678421.2019.1646769","article-title":"Neurofilaments in pre-symptomatic ALS and the impact of genotype","volume":"20","author":"Benatar","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.008_bib0945","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/jnnp-2021-326914","article-title":"Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications","volume":"92","author":"Saracino","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib0950","doi-asserted-by":"crossref","first-page":"e1466","DOI":"10.1212\/WNL.0000000000012632","article-title":"Prediagnostic neurofilament light chain levels in amyotrophic lateral sclerosis","volume":"97","author":"Bjornevik","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib0955","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.24552","article-title":"Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis","volume":"79","author":"Weydt","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0960","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/ene.15813","article-title":"Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"30","author":"Brousse","year":"2023","journal-title":"Eur J Neurol"},{"issue":"5796","key":"10.1016\/j.neurol.2025.07.008_bib0965","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neurol.2025.07.008_bib0970","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-018-1091-7","article-title":"TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"18","author":"Majumder","year":"2018","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0975","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","article-title":"A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD","volume":"30","author":"Irwin","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2025.07.008_bib0980","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg7162","article-title":"Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS\/FTD","volume":"16","author":"Seddighi","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurol.2025.07.008_bib0985","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1007\/s00415-020-10289-5","article-title":"The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?","volume":"268","author":"Chipika","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0990","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-019-02093-x","article-title":"Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis","volume":"139","author":"Oeckl","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2025.07.008_bib0995","doi-asserted-by":"crossref","first-page":"eaai7866","DOI":"10.1126\/scitranslmed.aai7866","article-title":"Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis","volume":"9","author":"Gendron","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurol.2025.07.008_bib1000","doi-asserted-by":"crossref","first-page":"859","DOI":"10.15252\/emmm.201607486","article-title":"Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS\/FTD","volume":"9","author":"Lehmer","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.neurol.2025.07.008_bib1005","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2217\/epi-2018-0072","article-title":"Mitochondrial DNA copy number and D-loop region methylation in carriers of amyotrophic lateral sclerosis gene mutations","volume":"10","author":"Stoccoro","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.neurol.2025.07.008_bib1010","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/acn3.51114","article-title":"CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis","volume":"7","author":"Gray","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1015","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/acn3.51674","article-title":"MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis","volume":"9","author":"Kmetzsch","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1020","first-page":"e811","article-title":"Prediagnostic plasma polyunsaturated fatty acids and the risk of amyotrophic lateral sclerosis","volume":"94","author":"O\u2019Reilly \u00c9J","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41582-023-00845-8","article-title":"Nutritional and metabolic factors in amyotrophic lateral sclerosis","volume":"19","author":"Ludolph","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ene.15584","article-title":"Mutation-specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis","volume":"30","author":"Xia","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/21678421.2024.2396831","article-title":"Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives","volume":"25","author":"Lee","year":"2024","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.008_bib1040","doi-asserted-by":"crossref","first-page":"e1955","DOI":"10.1212\/WNL.0000000000012829","article-title":"Life course of physical activity and risk and prognosis of amyotrophic lateral sclerosis in a German ALS Registry","volume":"97","author":"Rosenbohm","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1045","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.53.5.1059","article-title":"Nutritional status is a prognostic factor for survival in ALS patients","volume":"53","author":"Desport","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0b013e3182840689","article-title":"Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort","volume":"80","author":"Gallo","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1055","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jnnp.2010.211474","article-title":"Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients","volume":"82","author":"Marin","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1060","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/jnnp-2017-315795","article-title":"Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis","volume":"88","author":"Gorges","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/ene.15589","article-title":"Alzheimer's Disease Neuroimaging Initiative. Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis","volume":"30","author":"Chang","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1070","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s11682-022-00711-z","article-title":"Pre-symptomatic radiological changes in frontotemporal dementia: propagation characteristics, predictive value and implications for clinical trials","volume":"16","author":"McKenna","year":"2022","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.neurol.2025.07.008_bib1075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(14)70324-2","article-title":"Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis","volume":"14","author":"Rohrer","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1080","doi-asserted-by":"crossref","first-page":"102646","DOI":"10.1016\/j.nicl.2021.102646","article-title":"Differential early subcortical involvement in genetic FTD within the GENFI cohort","volume":"30","author":"Bocchetta","year":"2021","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurol.2025.07.008_bib1085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neurobiolaging.2017.10.008","article-title":"Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study","volume":"62","author":"Cash","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2025.07.008_bib1090","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nicl.2018.02.017","article-title":"Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers","volume":"18","author":"Popuri","year":"2018","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurol.2025.07.008_bib1095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2018.12.017","article-title":"Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study","volume":"76","author":"Panman","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2025.07.008_bib1100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ana.25748","article-title":"Faster cortical thinning and surface area loss in presymptomatic and symptomatic C9orf72 repeat expansion adult carriers","volume":"88","author":"Le Blanc","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1105","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.0000000000002135","article-title":"Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers","volume":"85","author":"Walhout","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nicl.2016.12.006","article-title":"Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers","volume":"14","author":"Lee","year":"2017","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurol.2025.07.008_bib1115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jalz.2019.08.196","article-title":"Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration","volume":"16","author":"Olney","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurol.2025.07.008_bib1120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jamaneurol.2017.4266","article-title":"Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers younger than 40 years","volume":"75","author":"Bertrand","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1125","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cortex.2020.08.023","article-title":"Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort","volume":"133","author":"Russell","year":"2020","journal-title":"Cortex"},{"key":"10.1016\/j.neurol.2025.07.008_bib1130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp-2020-323698","article-title":"In vivo PET imaging of neuroinflammation in familial frontotemporal dementia","volume":"92","author":"Malpetti","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1135","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/jnnp-2018-320265","article-title":"Gyrification abnormalities in presymptomatic c9orf72 expansion carriers","volume":"90","author":"Caverzasi","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1140","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.0000000000004393","article-title":"Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion","volume":"89","author":"Papma","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1145","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1007\/s00415-021-10575-w","article-title":"Infratentorial pathology in frontotemporal dementia: cerebellar grey and white matter alterations in FTD phenotypes","volume":"268","author":"McKenna","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuroimage.2018.11.063","article-title":"Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort","volume":"188","author":"Cury","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurol.2025.07.008_bib1155","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1007\/s00415-023-11764-5","article-title":"Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers","volume":"270","author":"Bede","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1160","doi-asserted-by":"crossref","first-page":"e2661","DOI":"10.1212\/WNL.0000000000201292","article-title":"Longitudinal brain atrophy rates in presymptomatic carriers of genetic frontotemporal dementia","volume":"99","author":"Poos","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1165","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.26572","article-title":"Longitudinal effects of asymptomatic C9orf72 carriership on brain morphology","volume":"93","author":"van Veenhuijzen","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1170","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/brain\/awr361","article-title":"Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features","volume":"135","author":"Mahoney","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.07.008_bib1175","doi-asserted-by":"crossref","first-page":"e16266","DOI":"10.1111\/ene.16266","article-title":"Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers","volume":"31","author":"Nigri","year":"2024","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1180","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.nicl.2016.10.014","article-title":"Longitudinal imaging in C9orf72 mutation carriers: relationship to phenotype","volume":"12","author":"Floeter","year":"2016","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurol.2025.07.008_bib1185","doi-asserted-by":"crossref","first-page":"e209623","DOI":"10.1212\/WNL.0000000000209623","article-title":"Progressive cerebrocerebellar uncoupling in sporadic and genetic forms of amyotrophic lateral sclerosis","volume":"103","author":"Tahedl","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1190","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/acn3.601","article-title":"Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: a cross-sectional diffusion tensor imaging study","volume":"5","author":"Jiskoot","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1195","doi-asserted-by":"crossref","first-page":"fcad061","DOI":"10.1093\/braincomms\/fcad061","article-title":"Genetic frontotemporal dementia initiative (GENFI). Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort","volume":"5","author":"Bocchetta","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurol.2025.07.008_bib1200","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/jnnp-2020-323671","article-title":"Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers-a developmental disorder","volume":"91","author":"Lul\u00e9","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1205","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nicl.2018.07.014","article-title":"Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI","volume":"20","author":"Feis","year":"2018","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurol.2025.07.008_bib1210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/jnnp-2018-318994","article-title":"Neurite density is reduced in the presymptomatic phase of C9orf72 disease","volume":"90","author":"Wen","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2020.11.014","article-title":"Longitudinal changes in network homogeneity in presymptomatic C9orf72 mutation carriers","volume":"99","author":"Waugh","year":"2021","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2025.07.008_bib1220","doi-asserted-by":"crossref","first-page":"102354","DOI":"10.1016\/j.nicl.2020.102354","article-title":"Longitudinal changes in resting state networks in early presymptomatic carriers of C9orf72 expansions","volume":"28","author":"Shoukry","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurol.2025.07.008_bib1225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neurobiolaging.2018.12.009","article-title":"Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia","volume":"77","author":"Rittman","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2025.07.008_bib1230","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/alz.12209","article-title":"Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia","volume":"17","author":"Tsvetanov","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurol.2025.07.008_bib1235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2020.1087","article-title":"Use of multimodal imaging and clinical biomarkers in presymptomatic carriers of C9orf72 repeat expansion","volume":"77","author":"De Vocht","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1240","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/brain\/awz039","article-title":"Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study","volume":"142","author":"Mutsaerts","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.07.008_bib1245","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ana.25520","article-title":"Presymptomatic spinal cord pathology in c9orf72 mutation carriers: a longitudinal neuroimaging study","volume":"86","author":"Querin","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1250","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/jnnp-2019-322242","article-title":"Cognitive inhibition impairments in presymptomatic C9orf72 carriers","volume":"91","author":"Montembeault","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1255","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/WNL.0b013e318231526a","article-title":"Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS","volume":"77","author":"Carew","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jmri.21217","article-title":"Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation","volume":"27","author":"Ng","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.neurol.2025.07.008_bib1265","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jnnp-2015-310734","article-title":"The cognitive profile of ALS: a systematic review and meta-analysis update","volume":"87","author":"Beeldman","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.008_bib1275","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.07.008_bib1280","doi-asserted-by":"crossref","first-page":"103649","DOI":"10.1016\/j.nicl.2024.103649","article-title":"Basal parasympathetic deficits in C9orf72 hexanucleotide repeat expansion carriers relate to smaller frontoinsula and thalamus volume and lower empathy","volume":"43","author":"Roy","year":"2024","journal-title":"NeuroImage Clin"},{"key":"10.1016\/j.neurol.2025.07.008_bib1285","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/01.WNL.0000156519.41681.27","article-title":"Cognitive change in ALS: a prospective study","volume":"64","author":"Abrahams","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1290","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/alz.12252","article-title":"Genetic FTD Initiative (GENFI). Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes","volume":"17","author":"Malpetti","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurol.2025.07.008_bib1295","first-page":"316","article-title":"Temporal course of cognitive and behavioural changes in motor neuron diseases","volume":"95","author":"McHutchison","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1300","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1212\/CPJ.0000000000001006","article-title":"Patterns of language impairment in early amyotrophic lateral sclerosis","volume":"11","author":"Pinto-Grau","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.neurol.2025.07.008_bib1305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(19)30394-1","article-title":"Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study","volume":"19","author":"Moore","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1310","doi-asserted-by":"crossref","first-page":"e12571","DOI":"10.1002\/dad2.12571","article-title":"Initiative (GENFI). Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia","volume":"16","author":"Samra","year":"2024","journal-title":"Alzheimers Dement (Amst)"},{"issue":"Suppl. 3","key":"10.1016\/j.neurol.2025.07.008_bib1315","first-page":"497","article-title":"Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment","volume":"8","author":"Finkel","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.neurol.2025.07.008_bib1320","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.neurol.2025.07.008_bib1325","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-160979","article-title":"NPS professional interest area of the international society of to advance Alzheimer's research and treatment (NPS-PIA of ISTAART). The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations","volume":"56","author":"Ismail","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2025.07.008_bib1330","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/WNL.0000000000000023","article-title":"Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival","volume":"82","author":"Mioshi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.07.008_bib1335","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/JAD-170632","article-title":"Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment Group","volume":"62","author":"Taragano","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2025.07.008_bib1340","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jagp.2019.12.007","article-title":"Clinical and MRI predictors of conversion from mild behavioural impairment to dementia","volume":"28","author":"Orso","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1345","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-201184","article-title":"Mild behavioral impairment and subjective cognitive decline predict cognitive and functional decline","volume":"80","author":"Ismail","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2025.07.008_bib1350","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/ene.15570","article-title":"Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases","volume":"30","author":"Ferraro","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/17482968.2010.520718","article-title":"How common are behavioural changes in amyotrophic lateral sclerosis?","volume":"12","author":"Lillo","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"issue":"Pt 12","key":"10.1016\/j.neurol.2025.07.008_bib1360","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1093\/brain\/awr297","article-title":"Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis","volume":"134","author":"Olney","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.07.008_bib1365","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mus.26617","article-title":"Amyotrophic lateral sclerosis: origins traced to impaired balance between neural excitation and inhibition in the neonatal period","volume":"60","author":"Kiernan","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2025.07.008_bib1370","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archneurol.2011.1021","article-title":"Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease","volume":"69","author":"Boxer","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1375","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/21678421.2015.1054292","article-title":"Eye-tracking in amyotrophic lateral sclerosis: a longitudinal study of saccadic and cognitive tasks","volume":"17","author":"Proudfoot","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.008_bib1380","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00415-009-0109-x","article-title":"Ocular fixation instabilities in motor neurone disease. A marker of frontal lobe dysfunction?","volume":"256","author":"Donaghy","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1385","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410380109","article-title":"Oculomotor function in amyotrophic lateral sclerosis: evidence for frontal impairment","volume":"38","author":"Shaunak","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1390","doi-asserted-by":"crossref","first-page":"10","DOI":"10.16910\/jemr.12.6.8","article-title":"Saccadic intrusions in amyotrophic lateral sclerosis (ALS)","volume":"12","author":"Becker","year":"2019","journal-title":"J Eye Mov Res"},{"key":"10.1016\/j.neurol.2025.07.008_bib1395","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2011.10.016","article-title":"Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population","volume":"314","author":"Moss","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2025.07.008_bib1400","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/21678421.2013.783077","article-title":"Early saccades in amyotrophic lateral sclerosis","volume":"14","author":"Burrell","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.008_bib1405","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s10072-020-04310-y","article-title":"Eye tracking metrics to screen and assess cognitive impairment in patients with neurological disorders","volume":"41","author":"Tao","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurol.2025.07.008_bib1410","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00415-023-11957-y","article-title":"Impairment of oculomotor functions in patients with early to advanced amyotrophic lateral sclerosis","volume":"271","author":"Aust","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1415","first-page":"1","article-title":"Exploring oculomotor challenges in amyotrophic lateral sclerosis: a comprehensive review","volume":"9","author":"Shen","year":"2025","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2025.07.008_bib1420","doi-asserted-by":"crossref","first-page":"e0142546","DOI":"10.1371\/journal.pone.0142546","article-title":"Eye movement deficits are consistent with a staging model of pTDP-43 pathology in amyotrophic lateral sclerosis","volume":"10","author":"Gorges","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2025.07.008_bib1425","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1007\/s00415-021-10510-z","article-title":"Eye movement alterations in presymptomatic C9orf72 expansion gene carriers","volume":"268","author":"Behler","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1430","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/bs.irn.2024.04.001","article-title":"Contribution of neurophysiology to the diagnosis and monitoring of ALS","volume":"176","author":"Vucic","year":"2024","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1435","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/brain\/awae049","article-title":"Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis","volume":"147","author":"Pavey","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.07.008_bib1440","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/jnnp-2012-304019","article-title":"Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights","volume":"84","author":"Vucic","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1445","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.3390\/ijms20112818","article-title":"Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques","volume":"20","author":"van den Bos","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurol.2025.07.008_bib1450","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WCO.0000000000001162","article-title":"Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis","volume":"36","author":"Timmins","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1455","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1388-2457(01)00523-5","article-title":"Mechanisms influencing stimulus-response properties of the human corticospinal system","volume":"112","author":"Boroojerdi","year":"2001","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1460","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.clinph.2008.01.011","article-title":"Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis","volume":"119","author":"Vucic","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1465","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.clinph.2017.05.005","article-title":"Cortical function and corticomotoneuronal adaptation in monomelic amyotrophy","volume":"128","author":"Matamala","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1470","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jnnp.2008.157537","article-title":"Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS","volume":"81","author":"Vucic","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1475","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.clinph.2010.12.062","article-title":"Cortical excitability distinguishes ALS from mimic disorders","volume":"122","author":"Vucic","year":"2011","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1480","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/acn3.51039","article-title":"Cortical hyperexcitability evolves with disease progression in ALS","volume":"7","author":"Menon","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1485","doi-asserted-by":"crossref","DOI":"10.1111\/ene.12669","article-title":"Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia","volume":"22","author":"Geevasinga","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1490","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2011.09.007","article-title":"Compensatory movement-related recruitment in amyotrophic lateral sclerosis patients with dominant upper motor neuron signs: an EEG source analysis study","volume":"1425","author":"Inuggi","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2025.07.008_bib1495","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jnnp-2017-315573","article-title":"Cortical influences drive amyotrophic lateral sclerosis","volume":"88","author":"Eisen","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1500","doi-asserted-by":"crossref","first-page":"e2030194","DOI":"10.1001\/jamanetworkopen.2020.30194","article-title":"Genetic FTD Initiative (GENFI).Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia","volume":"4","author":"Benussi","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.neurol.2025.07.008_bib1505","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/jnnp-2013-307135","article-title":"Amyotrophic lateral sclerosis: a long preclinical period?","volume":"85","author":"Eisen","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1510","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.clinph.2014.04.023","article-title":"Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS","volume":"126","author":"Menon","year":"2015","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1515","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/jnnp-2023-333039","article-title":"Effects of motor cortical and peripheral axonal hyperexcitability on survival in amyotrophic lateral sclerosis","volume":"95","author":"Otani","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1520","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/hbm.23357","article-title":"Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis","volume":"38","author":"Proudfoot","year":"2017","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.neurol.2025.07.008_bib1525","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa018","article-title":"The rise and fall of fasciculations in amyotrophic lateral sclerosis","volume":"2","author":"Bashford","year":"2020","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurol.2025.07.008_bib1530","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1097-4598(199702)20:2<179::AID-MUS7>3.0.CO;2-9","article-title":"A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis","volume":"20","author":"Felice","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2025.07.008_bib1535","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/jnnp.73.2.199","article-title":"Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation","volume":"73","author":"Aggarwal","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.07.008_bib1540","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/mus.26087","article-title":"Motor unit number index and neurophysiological index as candidate biomarkers of presymptomatic motor neuron loss in amyotrophic lateral sclerosis","volume":"58","author":"Escorcio-Bezerra","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2025.07.008_bib1545","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.clinph.2016.11.026","article-title":"Motor Unit Number Index (MUNIX) detects motor neuron loss in pre-symptomatic muscles in Amyotrophic Lateral Sclerosis","volume":"128","author":"Neuwirth","year":"2017","journal-title":"Clin Neurophysiol"},{"issue":"5 Suppl. 1","key":"10.1016\/j.neurol.2025.07.008_bib1550","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/17434470410020067","article-title":"The Neurophysiological Index in ALS","author":"Swash","year":"2004","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1016\/j.neurol.2025.07.008_bib1555","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adm7580","article-title":"Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse models","volume":"17","author":"Guillot","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurol.2025.07.008_bib1560","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/brain\/awad274","article-title":"Glymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis","volume":"147","author":"Liu","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.07.008_bib1565","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2025.07.008_bib1570","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.irn.2024.04.007","article-title":"Recent advances in the genetics of familial and sporadic ALS","volume":"176","author":"Al-Chalabi","year":"2024","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.neurol.2025.07.008_bib1575","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.neurol.2023.05.005","article-title":"French National Protocol for genetic of amyotrophic lateral sclerosis","volume":"179","author":"Corcia","year":"2023","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2025.07.008_bib1580","unstructured":"ClinicalTrials.gov. A study of BIIB067 (Tofersen) initiated in clinically presymptomatic adults with a confirmed superoxide dismutase 1 mutation (ATLAS). https:\/\/clinicaltrials.gov\/study\/NCT04856982 (Access on June 25, 2025)."}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:37:07Z","timestamp":1763177827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725005818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":158,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0035378725005818"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.07.008","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of presymptomatic amyotrophic lateral sclerosis: State of the art, practical implications and perspectives","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}